Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-904-6 | CAS number: 3658-48-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 18 Oct 2017 - 18 Jan 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- February 04, 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Direct Peptide Reactivity Assay (DPRA) for Skin Sensitization Testing, DB-ALM Protocol n°154
- Version / remarks:
- January 12, 2013
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- GLP-Landesleitstelle Bayer, Bayerrisches Landesamt für Gesundheit und Lebensmittelsicherheit
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- Bis(2-ethylhexyl) phosphonate
- EC Number:
- 222-904-6
- EC Name:
- Bis(2-ethylhexyl) phosphonate
- Cas Number:
- 3658-48-8
- Molecular formula:
- C16H35O3P
- IUPAC Name:
- bis(2-ethylhexyl) phosphonate
- Test material form:
- liquid
Constituent 1
In chemico test system
- Details on the study design:
- - Details of the test procedure used: The test item solutions were incubated with the cysteine and lysine peptide solutions in glass vials using defined ratios of peptide to test item (1:10 cysteine peptide, 1:50 lysine peptide). The reaction solutions were left in the dark at 25 ± 2.5 °C for 24 ± 2 h before running the HPLC analysis. If a precipitate or phase separation was observed in prior and after Incubation, samples might have been centrifuged at low speed (100 - 400x g) to force precipitates to the bottom of the vial.
A standard calibration curve was generated before the HPLC analysis of samples. Peptide depletion was monitored by HPLC coupled with an UV detector at λ = 220 nm using a reversed-phase HPLC column (Zorbax SB-C-18 2.1 mm x 100 mm x 3.5 micron) as preferred column. The entire system was equilibrated at 30 °C with 50% phase A and 50% phase B for at least 2 hours before running the analysis sequence. The HPLC analysis was performed using a flow rate of 0.35 mL/min and a linear gradient from 10% to 25% acetonitrile over 10 minutes, followed by a rapid increase to 90% acetonitrile. The column was re-equilibrated under initial conditions for 7 minutes between injections. Equal volumes of each standard, sample and control were injected.
HPLC analysis for the cysteine and lysine peptide was performed concurrently (if two HPLC systems were available) or on separate days. If analysis was conducted on separate days all test chemical solutions were freshly prepared for both assays on each day.
The analysis was timed to assure that the injection of the first sample started 22 to 26 hours after the test chemical was mixed with the peptide solution. The HPLC run sequence was set up in order to keep the HPLC analysis time less than 30 hours.
- Peptides used: cysteine peptide: Ac-RFAACAA; lysine peptide: Ac-RFAAKAA.
- Doses of test chemical and control substances used: test material: 100 mM stock solution of test substance; negative control: acetonitrile (undiluted); positive control: 100 mM stock solution of test substance.
The preparation of 1:10 Cysteine Peptide Run: 50 µL Test Item Stock Solution (100 mM) +200 µL acetonitrile +750 µL Peptide Stock Solution (0.667 mM)
The preparation of 1:50 Cysteine Peptide Run: 250 µL Test Item Stock Solution (100 mM) + 750 µL Peptide Stock Solution (0.667 mM)
- Duration and temperature of exposure period: 24 ± 2 h at 25 ± 2.5 °C.
- Co-elution Control used: the same solution preparation but use 750 µL buffer instead of Peptides, to check if test material or positive control co-elution with the Peptide Peaks.
- Number of replicates used per test chemical and controls: three replicates per treatment.
- Acceptance Criteria
The run meets the acceptance criteria if:
- the standard calibration curve has a r² > 0.99,
- the mean percent peptide depletion (PPD) value of the three replicates for the positive control is between 60.8% and 100% for the cysteine peptide and the maximum standard deviation (SD) for the positive control replicates is < 14.9%,
- the mean percent peptide depletion (PPD) value of the three replicates for the positive control is between 40.2% and 69.0% for the lysine peptide and the maximum SD for the positive control replicates is < 11.6%,
- the mean peptide concentration of the three reference controls A replicates is 0.50 ± 0.05 mM,
- the coefficient of variation (CV) of peptide peak areas for the six reference control B replicates and three reference control C replicates in acetonitrile is < 15.0%.
The results of the test item meet the acceptance criteria if:
- the maximum standard deviation (SD) for the test chemical replicates is < 14.9% for the cysteine percent depletion (PPD),
- the maximum standard deviation (SD) for the test chemical replicates is < 11.6% for the lysine percent depletion (PPD),
- the mean peptide concentration of the three reference controls C replicates in the appropriate solvent is 0.50 ± 0.05 mM.
- Evaluation criteria
By using the prediction model 1 (cysteine 1:10 / lysine 1:50 prediction model), the threshold of 6.38% average peptide depletion was used to support the discrimination between skin sensitisers and non-sensitisers.
By using the prediction model 1 (cysteine 1:10 model), the threshold of 13.89% average peptide depletion was used to support the discrimination between skin sensitisers and non-sensitisers.
Results and discussion
- Positive control results:
- The acceptance criteria for the depletion range of the positive control were fulfilled.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: cystein
- Parameter:
- other: mean peptide depletion [%]
- Value:
- 0.4
- Vehicle controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: non-sensitiser
- Key result
- Run / experiment:
- other: lysine
- Parameter:
- other: mean peptide depletion [%]
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: non-sensitiser
- Other effects / acceptance of results:
- - The substance was dissolved in acetonitrile.
- For the 100 mM stock solution of the test item no turbidity or precipitation was observed when diluted with the cysteine peptide solution and with the lysine peptide solution.
- No co-elution of test item with the peptide peaks was observed.
- Precipitation and phase separation were observed for the samples of the positive control. Since the acceptance criteria for the depletion range of the positive control were fulfilled, the observed precipitation and phase separation were regarded as insignificant.
Any other information on results incl. tables
Table 1: Depletion of the CysteinePeptide
Cysteine Peptide |
||||||
Sample |
Peak Area at 220 nm |
Peptide Conc. [mM] |
Peptide Depletion [%] |
Mean Peptide Depletion [%] |
SD of Peptide Depletion [%] |
CV of Peptide Depletion [%] |
Positive Control |
1320.4471 |
0.1577 |
70.95 |
|
|
|
1315.4908 |
0.1571 |
71.06 |
71.10 |
0.18 |
0.25 |
|
1304.7782 |
0.1559 |
71.29 |
|
|
|
|
Test Item |
4537.9878 |
0.5364 |
0.15 |
|
|
|
4580.9971 |
0.5414 |
0.00 |
0.40 |
0.56 |
141.03 |
|
4497.4966 |
0.5316 |
1.05 |
|
|
|
Table 2: Depletion of the LysinePeptide
Lysine Peptide |
||||||
Sample |
Peak Area at 220 nm |
Peptide Conc. [mM] |
Peptide Depletion [%] |
Mean Peptide Depletion [%] |
SD of Peptide Depletion [%] |
CV of Peptide Depletion [%] |
Positive Control |
1690.0214 |
0.2164 |
56.37 |
|
|
|
1699.1774 |
0.2175 |
56.14 |
56.51 |
0.47 |
0.83 |
|
1664.2920 |
0.2131 |
57.04 |
|
|
|
|
Test Item |
3974.3203 |
0.5085 |
0.00 |
|
|
|
3991.4160 |
0.5107 |
0.00 |
0.00 |
0.00 |
-- |
|
3932.5691 |
0.5031 |
0.00 |
|
|
|
Table 3:Categorization of the Test Item
Prediction Model |
Prediction Model 1 (Cysteine Peptide and Lysine Peptide / Ratio: 1:10 and 1:50) |
Prediction Model 2 (Cysteine Peptide / Test Item Ratio: 1:10) |
||||
Test Substance |
Mean Peptide Depletion [%] |
Reactivity Category |
Prediction |
Mean Petide Depletion [%] |
Reactivity Category |
Prediction |
Test Item |
0.20 |
Minimal Reactivity |
no sensitiser |
0.40 |
Minimal Reactivity |
no sensitiser |
Positive Control |
63.81 |
High Reactivity |
sensitiser |
71.10 |
Moderate Reativity |
sensitiser |
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- In this study under the given conditions the test item showed minimal reactivity towards both peptides. The test item can be considered as “non-sensitiser”.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.